The non-technological roadmap aims to identify regulatory and non-technological hurdles that may inhibit innovation and prevent the realization of the market and technological potential of IB. Furthermore, the non-technological roadmap seeks to propose solutions to these hurdles by confronting theory and practice. This takes the form of identifying and proposing solutions for key market entry barriers, going beyond recommendations already formulated by other initiatives and projects on biobased products, and preparing a study for policy makers.


The current version of the roadmap is based on an extensive literature study and the subsequent stakeholder confrontation of its findings during eight regional workshops and more than 60 expert interviews. The regional workshops not only sought the validation of the hurdles found in the literature but also aimed at highlighting the most compelling ones to the people involved daily in IB. Several barriers of IB in general were found particularly worrisome throughout the workshops. These include feedstock related barriers in terms of price and quantity; financial barriers in terms of capital requirements and high investment risk; hurdles related to public perception and communication; and bottlenecks related to the few demand side policies in the field. By gathering workshop participants with different backgrounds and mindsets, but also through the in-depth discussion with IB-experts during the interviews, several tentative solutions to the mentioned hurdles were developed.

Hurdles and proposed solutions

The workshops and interviews have inevitably engaged experts with different interests and focus areas, enabling the BIO-TIC partners to push the exercise even further and find concrete information related to the specificities of the business cases. This is how it was pointed out that the food versus fuel debate and its effects on public acceptance, environmental concerns and ultimately the loss of legislative support have created a trauma in the biofuels sector and hindered the development of advanced biofuels. In the case of chemical building blocks, the core issue appeared to be the lack of general interest in biochemical production, whether it is expressed by the little investments, policies or market incentives for CBB’s. The biobased plastics business case is mainly faced with problems related to price, lack of critical mass and real regulatory support to foster its competitiveness. The biosurfactants experts revealed that the substantial part of their concerns is related to the high cost of upscaling or building new production plants in order to reach the commercial scale. In light of its still early stage development, CO2 as a feedstock essentially requires more R&D funding to become operational.


Would you like to know more? Download the complete version of the roadmap here.
Your input is important to us. Send your comments to the co-ordinator of the BIO-TIC project, Claire Gray, at

diazepam online no prescription diazepam online without prescription order diazepam online buy ultram without prescriptions ultram online no prescription buy ultram online no prescription overnight provigil overnight shipping buy provigil online cheap provigil no prescription buy soma for dogs buy soma without prescription cheap soma buy phentermine with mastercard buy phentermine online no prescription phentermine online tramadol generic buy tramadol no prescription buy tramadol no prescription overnight adipex generic buy adipex online no prescription adipex online buy valium free shipping buy valium online no prescription buy cheap valium buy xanax tablet xanax online no prescription buy xanax cheap no prescription buy klonopin no prescription buy klonopin online without prescription klonopin no rx